Biosimulation Market to Witness the Highest Growth During The Forecast Period To 2020

1
MarketsandMarkets Presents
Biosimulation Market to Witness the Highest
Growth During The Forecast Period
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
2
The report Biosimulation Market by Product
(Software, Molecular Modeling, PB/PK, PKPD, Trial
Design, Toxicity Prediction, In-house, Contract
Service), by Application (Drug Discovery
Development, Preclinical, Clinical Trial), by End
Users - Global Forecast to 2020, provides a
detailed overview of the major drivers,
restraints, and opportunities impacting the
global biosimulation market along with the
estimates and forecasts of the revenue and market
share analysis. Browse 75 market data
tables,64figures 150 pages And in-depth TOC on
Biosimulation Market Get The PDF Brochure For
This Report http//www.marketsandmarkets.com/pdf
download.asp?id838 The biosimulation market
is expected to reach USD 2,107.99 Million by 2020
from USD 1,034.93 Million in 2015, at a CAGR of
15.29.
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
3

• The major drivers for the biosimulation market
  include the strong trend of RD investments in
  biotechnology and pharmaceutical industries the
  need to curtail drug discovery development
  costs growth in the biologics and biosimilars
  market increased use of personalized medicines
  technological advancements and the trend of
  periodic product upgradation.
•  
• Scope of the Report
• This report categorizes the global market into
  the following segments
• Global Market, by Product
• Global Market, by Application
• Global Market, by End User
• Global Market, by Geography
• Request a sample of the report
  http//www.marketsandmarkets.com/requestsample.asp
  ?id838

http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
4
Industry Insights In this report, the global
biosimulation market is segmented based on
product, application, end user, and geography. By
product, the market includes software and
services. The software segment includes molecular
modeling and simulation software, PBPK modeling
and simulation software, PK/PD modeling and
simulation software, trail design software,
toxicity prediction software, and other software
(QSP, visualizing and analytical software). The
services segment includes in-house services and
external/contract services. Based on
applications, the market is segmented into drug
discovery, drug development, and others (defense,
industrial bioprocessing, nutraceuticals, and
agri-food production). The drug development
application segment is further classified into
preclinical testing and clinical trials. The drug
discovery segment is divided into target
identification validation and lead
identification optimization.
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
5
Geographical Scenario The geographic segments
included in this report are North America,
Europe, Asia, and the Rest of the World (RoW). In
2015, the North America is expected to command
the largest share of the global biosimulation
market. Europe is expected to register the
highest growth due to increasing government
funding and the large number of pharmaceuticals
and biotechnology companies in this
region. Industry Leaders The major players in
the global biosimulation market are Certara USA,
Inc. (U.S.), Simulation Plus Inc. (U.S.),
Dassault Systèmes SA (France), Schrödinger Inc.
(U.S.), Advanced Chemistry Development, Inc.
(Canada), Chemical Computing Group, Inc.
(Canada), Physiomics PLC (U.K.), Entelos Holding
Corporation (U.S.), Rhenovia Pharma Ltd.
(France), and Genedata AG (Switzerland).
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets